Tech Pivots to Cloud Mega-Deals as AI Momentum Spills Into BiopharmaGlobal Report·1 day ago, 04:17 AMAKAM-0.49%GENB-3.41%
Deconstructing the Value Chain of the Long Tail: From Physical Scarcity to Niche AggregationGlobal Report·2 days ago, 04:13 AMNXE+2.94%METC+4.80%
The Great Biotech Reckoning: When AI and Gene Editing Meet Wall Street's Patience in 2026Global Report·Jul 19 at 04:13 AMAMGN-5.00%CRSP-1.89%
M&A, AI Drug Discovery, and Late-Stage Clinical Readouts Define US Biotech Q2 TrajectoryGlobal Report·Jul 18 at 04:13 AMAMGN-5.00%CRSP-1.89%
Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Sessionbenzinga_article·Jul 1 at 07:02 AMPZZA-0.90%NRGV-3.74%
Cathie Wood Loads Up On Amazon Stock After Record $26.4 Billion Prime Day, Bets Big On Palantir's AI Push — Keeps Dumping Alibababenzinga_article·Jun 29 at 10:04 PMABSI-0.96%PLTR-6.10%
Generate Biomedicines releases corporate presentation on programmable biology platform and clinical-stage pipelinePUBT·Jun 29 at 10:47 AMGENB-3.41%
Nvidia Owns This Under-the-Radar $20 Stock Poised to Disrupt a $1.8 Trillion MarketMotley Fool·Jun 27 at 07:10 AMGENB-3.41%NVDA+2.30%
Global Cross-Border Pressures Reshape US Pharma and Next-Gen Supply ChainsGlobal Report·Jun 18 at 07:51 AMTEVA-3.83%GENB-3.41%
LLY, COIN, HOOD, and ROKU Stocks in Focus: Cathie Wood Sells Winners and Buys New Catalysts — 6/18/26Tip Ranks·Jun 18 at 05:43 AMROKU-0.82%GENB-3.41%
A New $21 Million Position Signals Confidence in This Post-IPO Drug Developernasdaq·May 31 at 03:50 PMGENB-3.41%
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference | GENB Stock NewsStockTitan·May 28 at 07:20 AMGENB-3.41%
Generate Biomedicines shares are trading higher after a 13F filing revealed NVIDIA took a new 833,325-share stake.benzinga_article·May 15 at 03:26 PMNVDA+2.30%GENB-3.41%
